A large Nature Medicine study inferred cell-type aging from plasma proteins. The model predicted risk at population level, but it is not a diagnosis or validated clinic treatment engine.
A buyer-focused guide to epigenetic testing at longevity clinics: when biological-age clocks add useful context, when they become sales theater, and what to ask before paying.
A buyer guide to longevity clinic data systems: wearables, dashboards, clinical records, AI, interoperability, privacy, escalation, and proof to request.
A practical 2026 guide to biological age testing in longevity clinics: epigenetic clocks, proteomic and multi-omics clocks, imaging-derived organ age, inflammatory markers, and the clinical tests that actually change decisions.
